share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Samuels Theodore R. II

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施貴寶 | 4：持股變動聲明
SEC announcement ·  04/03 06:46
牛牛AI助理已提取核心訊息
Samuels Theodore R. II, associated with Bristol-Myers Squibb (BMY), was involved in a transaction on 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
Samuels Theodore R. II, associated with Bristol-Myers Squibb (BMY), was involved in a transaction on 03/31/2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and there was no information provided regarding the number of shares held after the action.
與百時美施貴寶（BMY）有聯繫的塞繆爾·西奧多·R.II於2024年3月31日參與了一筆交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。沒有具體說明塞繆爾與發行人的關係，也沒有提供有關訴訟後持有的股票數量的信息。
與百時美施貴寶（BMY）有聯繫的塞繆爾·西奧多·R.II於2024年3月31日參與了一筆交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。沒有具體說明塞繆爾與發行人的關係，也沒有提供有關訴訟後持有的股票數量的信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。